EchoGo Pro vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoGo Pro

by Ultromics

iCAC Device

by Bunkerhill Health

AI Verdict

EchoGo Pro and iCAC Device both leverage AI to enhance cardiac diagnosis but focus on distinct imaging modalities and clinical applications. EchoGo Pro automates stress echocardiography analysis for coronary artery disease diagnosis, while iCAC Device detects and quantifies coronary artery calcium from routine chest CT scans for early cardiovascular disease detection. Therefore, they serve complementary roles within cardiovascular care rather than being direct substitutes.

Choose EchoGo Pro if…

Choose EchoGo Pro if your cardiology department requires an AI-powered solution for automating stress echocardiography analysis to rapidly and accurately diagnose coronary artery disease. This tool is ideal for clinics seeking near-instant, comprehensive reports and seamless integration with existing PACS and clinical workflows, enhancing diagnostic accuracy without extensive software installation.

View EchoGo Pro →

Choose iCAC Device if…

Choose iCAC Device if your radiology or cardiology practice aims to opportunistically identify and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans. This solution is best for leveraging existing imaging data to aid in early cardiovascular disease detection and risk stratification, providing valuable adjunctive information to radiologists.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoGo Pro	iCAC Device
Pricing	Contact vendor for pricing	Contact for pricing
Deployment	Cloud-based	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro explicitly states that its SaaS model requires no software installation or extensive training, and it is vendor-neutral, compatible with any PACS. While iCAC Device also emphasizes seamless integration and efficiency, EchoGo Pro's direct claims regarding ease of setup and broad compatibility give it a slight edge in initial usability and adoption.

Clinical Value

iCAC Device

While EchoGo Pro improves diagnostic accuracy for coronary artery disease from stress echocardiograms, iCAC Device offers significant clinical value through opportunistic identification and quantification of coronary artery calcium from routine, non-contrast chest CT scans. This enables early detection and risk stratification in a broader patient population who might otherwise go undiagnosed, leading to proactive management and potentially reducing long-term cardiovascular costs.

Pricing & Value

iCAC Device

Both tools require contacting the vendor for pricing. However, Bunkerhill Health's iCAC Device has secured a CMS reimbursement pathway for AI cardiovascular analysis, which significantly enhances its financial viability and value proposition for health systems. While EchoGo Pro mentions flexible payment schemes and reimbursement codes for related products, a direct reimbursement pathway for the specific type of analysis iCAC performs provides a clearer path to value realization.

Enterprise Readiness

Tie

Both tools are FDA-cleared and offer robust integration capabilities with existing clinical workflows. While EchoGo Pro explicitly states HIPAA compliance and BAA availability in its structured facts, web search confirms Bunkerhill Health is also HIPAA compliant, SOC 2, and ISO 27001:2022 certified, providing strong evidence of its enterprise readiness. Therefore, both demonstrate comparable readiness for enterprise deployment.

Innovation

iCAC Device

Both tools leverage AI innovatively in cardiology. EchoGo Pro automates and standardizes the complex interpretation of stress echocardiograms, improving diagnostic accuracy. However, iCAC Device's innovation in opportunistically detecting and quantifying coronary artery calcium from *routine, non-cardiac* CT scans is particularly impactful, transforming existing data into a powerful tool for population-level cardiovascular risk assessment and early intervention.

Support & Docs

EchoGo Pro

EchoGo Pro explicitly mentions the availability of a 'Clinician User Manual' and 'Operator Manual' for its software, and lists 'Customer Support' on its website. In contrast, the provided information for iCAC Device does not detail specific documentation or dedicated support channels, making EchoGo Pro appear more transparent regarding its support resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoGo Pro	iCAC Device
Name	EchoGo Pro	iCAC Device
Company	Ultromics	Bunkerhill Health
Primary Function	Automates stress echocardiography analysis to improve the diagnosis of coronary artery disease.	Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Input Data Type	Echocardiograms	Routine, non-contrast, non-gated chest CT scans
Key Output/Analysis	Near-instant, comprehensive reports for coronary artery disease diagnosis.	Estimates presence and quantity of coronary artery calcium (CAC), visual representation of estimated CAC segmentation, and quantitative estimates of CAC burden in Agatston units.

Videos

Demos, reviews, and walkthroughs featuring EchoGo Pro and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary diagnostic focus of each AI tool?

EchoGo Pro is designed to automate stress echocardiography analysis to improve the diagnosis of coronary artery disease (CAD). The iCAC Device, on the other hand, detects and quantifies coronary artery calcium (CAC) from routine chest CT scans to aid in early cardiovascular disease detection.

What type of imaging data is required for each tool's analysis?

EchoGo Pro analyzes stress echocardiograms to provide its diagnostic insights. In contrast, the iCAC Device processes routine, non-contrast, non-gated chest CT scans to identify and quantify coronary artery calcium.

How do these tools integrate into existing clinical workflows?

EchoGo Pro is a cloud-based, vendor-neutral system that integrates seamlessly with existing clinical workflows via DICOM and HL7, and is compatible with any PACS. The iCAC Device, as a Software as a Medical Device (SaMD), integrates with PACS or a DICOM router and supports EHR integration through the Carebricks platform.

Are there specific reimbursement codes available for using these tools?

For EchoGo Pro, reimbursement codes are available for related EchoGo products, specifically CPT 0932T for EchoGo Heart Failure and NTAP XXE2X19 for inpatient settings. The iCAC Device's pricing details state 'N/A' for reimbursement codes.

What specific diagnostic outputs and quantitative information do these tools provide?

EchoGo Pro provides near-instant, comprehensive reports to improve diagnostic accuracy and reduce misdiagnosis of coronary artery disease. The iCAC Device outputs a visual representation of estimated CAC segmentation and delivers exact and four-category quantitative estimates of CAC burden in Agatston units.